Mohamed Kharfan-Dabaja, Vice Chair of Hematology at Mayo Clinic Comprehensive Cancer Center, shared a post on X:
“We are happy to share our recently published clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and CAR T-cell therapy in chronic lymphocytic leukemia on behalf of ASTCT.”
Title: Clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy in patients with chronic lymphocytic leukemia on behalf of the American Society for Transplantation and Cellular Therapy
Authors: Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Javier Pinilla-Ibarz, Jennifer R. Brown, Mazyar Shadman, Farrukh T. Awan, Saad S. Kenderian, Tanya Siddiqi, Jeremy S. Abramson, Taha Al-Juhaishi, Danielle M. Brander, Catherine C. Coombs, Richard R. Furman, Nitin Jain, Nadia Khan, Nakhle S. Saba, Jennifer M. Collins, Amer Beitinjaneh, Deborah M. Stephens, Jennifer Woyach, Mehdi Hamadani
More Posts featuring Mohamed Kharfan-Dabaja.